Om Namo Traithep Co.,ltd. is a Company Limited, established on 28 Jan 2013 and registered in Chiangmai, Thailand. The Company’s principal business is manufacture of pharmaceuticals, medicinal chemical products. Om Namo Traithep Co.,ltd. has been operating for 13 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Om Namo Traithep Co.,ltd.
- Registration number
- 0505556001044
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 28 Jan 2013
- Registered capital (THB)
- THB 1,000,000
- Industry group
- Manufacturing
- TSIC activity
- Manufacture of pharmaceuticals, medicinal chemical products
Contact DetailsRegistered contact information
- Registered address
- 20, Ratchawithi, Sri Phom, Muang, Chiang Mai 50200
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
- Supanya ChangtrakulDirector
ShareholderShareholding of Om Namo Traithep Co.,ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Om Namo Traithep Co.,ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Om Namo Traithep Co.,ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
Litigation checks for Om Namo Traithep Co.,ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
Regulatory checks for Om Namo Traithep Co.,ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse media checks for Om Namo Traithep Co.,ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals
